SCIOSCIA, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 3.568
EU - Europa 3.369
AS - Asia 2.879
SA - Sud America 578
AF - Africa 67
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 10.473
Nazione #
US - Stati Uniti d'America 3.475
SG - Singapore 1.247
IE - Irlanda 833
RU - Federazione Russa 665
CN - Cina 555
BR - Brasile 467
HK - Hong Kong 427
SE - Svezia 397
IT - Italia 368
VN - Vietnam 277
FR - Francia 241
DE - Germania 234
UA - Ucraina 158
FI - Finlandia 123
IN - India 93
GB - Regno Unito 86
RO - Romania 60
CA - Canada 52
TR - Turchia 39
IQ - Iraq 38
NL - Olanda 38
BD - Bangladesh 36
CZ - Repubblica Ceca 36
AR - Argentina 33
PL - Polonia 25
ES - Italia 23
JP - Giappone 23
MX - Messico 21
ID - Indonesia 20
EC - Ecuador 19
AT - Austria 17
BE - Belgio 15
PK - Pakistan 15
CO - Colombia 14
LT - Lituania 13
CL - Cile 12
ZA - Sudafrica 12
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
KE - Kenya 10
MY - Malesia 10
MA - Marocco 9
NO - Norvegia 9
SA - Arabia Saudita 9
EG - Egitto 8
JO - Giordania 8
UY - Uruguay 8
VE - Venezuela 8
AZ - Azerbaigian 7
PH - Filippine 7
DO - Repubblica Dominicana 6
LB - Libano 6
DZ - Algeria 5
KZ - Kazakistan 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
AU - Australia 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PE - Perù 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
JM - Giamaica 3
KG - Kirghizistan 3
OM - Oman 3
SY - Repubblica araba siriana 3
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
KR - Corea 2
KW - Kuwait 2
MK - Macedonia 2
ML - Mali 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
DJ - Gibuti 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
Totale 10.462
Città #
Dublin 833
San Jose 811
Singapore 614
Hong Kong 421
Ashburn 408
Chandler 401
Nyköping 294
Beijing 200
Dallas 163
Santa Clara 138
Lauterbourg 133
Munich 101
Ho Chi Minh City 100
New York 98
Moscow 95
Jacksonville 94
The Dalles 87
Helsinki 76
Princeton 73
Los Angeles 62
Boardman 60
Timisoara 56
Hanoi 53
Frankfurt am Main 51
Dearborn 49
Turku 38
Foggia 34
São Paulo 34
Wilmington 32
Nanjing 31
Pune 28
Brno 25
Ann Arbor 23
Bari 23
Düsseldorf 21
Hillsboro 21
Nuremberg 21
Warsaw 21
Rio de Janeiro 20
Brooklyn 18
Chicago 18
Falkenstein 18
London 18
Milan 18
Rome 18
San Francisco 18
Toronto 18
Tokyo 17
Seattle 16
Shanghai 16
Des Moines 15
Guangzhou 15
Haiphong 15
Stockholm 15
Boston 14
Brussels 14
Council Bluffs 14
Nanchang 14
Phoenix 13
Chennai 12
Da Nang 12
Washington 12
Amsterdam 11
Buffalo 11
Chengdu 11
Orem 11
Dhaka 10
Montreal 10
Atlanta 9
Baghdad 9
Belo Horizonte 9
Hải Dương 9
Porto Alegre 9
Wuhan 9
Denver 8
Istanbul 8
Jiaxing 8
Nairobi 8
Oslo 8
Paris 8
San Mateo 8
Shenyang 8
Tashkent 8
Vienna 8
Amman 7
Ankara 7
Biên Hòa 7
Brasília 7
Charlotte 7
Cutrofiano 7
Jinan 7
Kuala Lumpur 7
Manchester 7
New Delhi 7
Portsmouth 7
Prague 7
Ribeirão Preto 7
Baku 6
Curitiba 6
Florence 6
Totale 6.508
Nome #
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype 162
Emorragia alveolare diffusa (DAH): recidiva della granulomatosi di Wegener dopo un trattato inadeguato 155
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 153
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 130
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 123
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 122
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 122
Exhaled breath condensate and respiratory diseases 121
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 121
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 118
Assessing value of contrast-enhanced ultrasound vs. conventional transthoracic ultrasound in improving diagnostic yield of percutaneous needle biopsy of peripheral lung lesions 113
Mortality in obstructive sleep apnea syndrome (OSAS) and overlap syndrome (OS): The role of nocturnal hypoxemia and CPAP compliance 111
Effetti a lungo termine della terapia con omalizumab, in pazienti con asma severo persistente non controllato 111
A case of severe allergic eosinophilic asthma with nasal polyposis in a patient affected by birt-hogg-dubé syndrome successfully treated with benralizumab 108
MicroRNA expression profile during different conditions of hypoxia 106
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients With COVID-19 105
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 104
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 104
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 102
Low sensitivity of admission lung us compared to chest ct for diagnosis of lung involvement in a cohort of 82 patients with covid-19 pneumonia 98
Imaging profile after treatment with Tocilizumab in COVID-19: a case series 97
Omalizumab as add-on therapy in a patient with severe asthma and OSA 97
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 96
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 96
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients with COVID-19 96
Chest Imaging in the Diagnosis and Management of Pulmonary Tuberculosis: The Complementary Role of Thoraci Ultrasound 95
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 94
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 94
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 93
Disturbo bipoplare tipo II: un caso di disassuefazione tabagica e reinserimento sociale 92
Tabagismo e malattie fumo-correlate 92
Chylothorax found in a patient with COVID-19 92
Molecular study of the lung microbiome in patients with non-cystic fibrosis bronchiectasis: the contribution of Pseudomonas aeruginosa infection to clinical outcomes 91
Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis 91
Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis 89
Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 “Glitters” 89
A Report on a Targeted Screening Population for Alpha-1-Antitrypsin Deficiency (AATD) in Central-Southern Italy 88
Asma bronchiale 88
Machine learning-based prediction of adherence to continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA) 88
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 88
Knowledge of telemedicine in a sleep clinic during the COVID-19 pandemic by a phone survey 87
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study 87
Association between physical activity and risk of hospitalisation in bronchiectasis 87
Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study 86
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 86
The Role of Transthoracic Ultrasound in the Study of Interstitial Lung Diseases: High-Resolution Computed Tomography Versus Ultrasound Patterns: Our Preliminary Experience 86
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 86
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 86
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 86
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients 85
Different Expression of Micro-RNA in the Subcutaneous and Visceral Adipose Tissue of Obese Subjects 84
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 84
Exhaled breath temperature in NSCLC: Could be a new non invasive marker? 83
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 83
Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAHS): state of the art 82
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 82
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 81
COVID-19 Pneumonia: The Great Ultrasonography Mimicker 81
How Are We Handling the Post-COVID Patients? The Dance of Uncertainties 81
Chylothorax found in a patient with COVID-19 81
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 80
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 80
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 80
Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions 80
A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians 79
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 79
Could transthoracic ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma? 78
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 77
Transthoracic ultrasound sign in severe asthmatic patients: a lack of “gliding sign” mimic pneumothorax 77
Clinical Features of SARS-COV-2 Infection After Full Vaccination in Health Care Workers of a COVID Hospital 76
Transthoracic Ultrasound in Infectious Organizing Pneumonia: A Useful Guide for Percutaneous Needle Biopsy 76
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study 75
Efficacy of prone positioning in COVID-19 pneumonia according to radiological phenotypes 75
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 74
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 73
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 72
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 71
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 71
Breath and Sputum Analyses in Asthmatic Patients: An Overview 70
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 69
Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience 67
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 67
MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma 66
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 65
A preliminary report of gender differences in residual sleepiness of CPAP-treated obstructive sleep apnea 64
EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases 64
Thoracic ultrasound combined with low-dose computed tomography may represent useful screening strategy in highly exposed population in the industrial city of Taranto (Italy) 64
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 64
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 64
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 63
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 63
Controlling Nutritional Status Score as a Predictor for Chronic Obstructive Pulmonary Disease Exacerbation Risk in Elderly Patients 62
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 62
The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study 61
Searching for airways biomarkers useful to identify progressive pulmonary fibrosis 61
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension 60
The CORE syndrome: an overlap of severe asthma, obstructive sleep apnea, rhinosinusitis, and esophageal reflux 59
Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time 59
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 59
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 59
Totale 8.684
Categoria #
all - tutte 63.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 31 2 13
2021/2022397 25 1 4 7 45 6 22 22 57 87 4 117
2022/20232.062 157 96 105 88 123 213 11 179 976 15 41 58
2023/2024514 78 16 20 11 36 113 36 33 11 12 5 143
2024/20252.634 110 41 92 64 81 375 235 191 542 285 342 276
2025/20264.517 365 411 537 523 232 256 927 596 370 300 0 0
Totale 10.955